| Dr Bruce Alan Blanchard, DDS | |
|
5501 Woodside Ave, Myrtle Beach, SC 29577-2243 | |
| (843) 449-5035 | |
| Not Available |
| Full Name | Dr Bruce Alan Blanchard |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 5501 Woodside Ave, Myrtle Beach, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275682544 | NPI | - | NPPES |
| ZA9831 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 2973 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bruce Alan Blanchard, DDS 5501 Woodside Ave, Myrtle Beach, SC 29577-2243 Ph: (843) 449-5035 | Dr Bruce Alan Blanchard, DDS 5501 Woodside Ave, Myrtle Beach, SC 29577-2243 Ph: (843) 449-5035 |
News Archive
The Institute of Medicine offers an analysis of how the money is misspent and some steps that might address these trouble spots.
A team of scientists recently investigated and compared the efficacy of spike-based and nucleocapsid-based COVID-19 vaccines in mice infected with SARS-CoV-2. Their findings reveal that nucleocapsid-based vaccines are effective in preventing SARS-CoV-2 infection in distal organs, such as the brain.
MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that it has filed an Investigational New Drug (IND) application with the State Food and Drug Administration (SFDA) in China for MRX-I, its first development-stage antibiotic drug candidate. MRX-I, an orally-administered oxazolidinone, targets multi-drug resistant Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
Oncothyreon Inc., a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it has acquired Alpine Biosciences, Inc., of Seattle, Washington, a privately held biotechnology company developing protocells, a nanoparticle platform technology designed to enable the targeted delivery of multiple therapeutic agents, including nucleic acids, proteins, peptides and small molecules.
› Verified 2 days ago
Dr. William Christopher Harding Iv, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 100 Debo Dr, Myrtle Beach, SC 29579 Phone: 843-236-8848 Fax: 843-236-8857 | |
Juan Faja-fernandez, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 107 Surgeons Drive, Myrtle Beach, SC 29579 Phone: 843-206-1116 | |
Dr. Will Abdelmalik, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1209 N Retail Ct, Myrtle Beach, SC 29577 Phone: 843-874-4060 | |
Dr. Justin Dammann, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 501 Pennington Loop, Myrtle Beach, SC 29588 Phone: 843-446-3664 | |
Dr. Vasilios Pournaras, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1211 44th Ave. N., Suite 100, Myrtle Beach, SC 29577 Phone: 843-449-3161 Fax: 843-449-9785 | |
Johnathan T Steppe, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 568 International Drive, Myrtle Beach, SC 29579 Phone: 217-540-5100 | |
Tiffiany Gosnell, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1430 S Commons Dr, Myrtle Beach, SC 29588 Phone: 843-712-7308 |